Charley Mackenzie-Kludas

Author

The University of Melbourne

Also Known As

Charley J. MacKenzie-Kludas, Charley MacKenzie‐Kludas, Charley Mackenzie-Kludas, Engwerda, Christian R

Publications

615

Citations

H-Index

Concepts

All Affiliations

The University of Melbourne Peter Doherty Institute Monash University Walter and Eliza Hall Institute of Medical Research CSL (Australia)

About

Charley Mackenzie-Kludas is an author at The University of Melbourne specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	247
2	Health Sciences	1	1	12
3	Allergy	1	1	12
4	Cell Biology	1	1	14
5	Cellular Therapies	1	1	12

Charley Mackenzie-Kludas

Publications

593

Citations

H-Index

Page 1

	Year	Citations
Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease Julie McAuley, Michelle D. Tate, Charley Mackenzie-Kludas, PLoS Pathogens	2013	255
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection Richard J. Mills, Sean J. Humphrey, Patrick R.J. Fortuna, Cell InflammationSars-cov-2 InfectionImmunologyAntiviral ResponseMedicine	2021	209
Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis Ian K. Campbell, David Tai Leong, Kirsten M. Edwards, The Journal of Immunology	2016	81
Activin inhibits telomerase activity in cancer Indzi Katik, Charley Mackenzie-Kludas, Craig Nicholls, Biochemical and Biophysical Research Communications OncologyOncogenic AgentMedicineTelomerase ActivityTumor Suppressor	2009	14
Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model Sandra Koernig, Ian K. Campbell, Charley Mackenzie-Kludas, Mucosal Immunology Acute Lung InjuryInflammatory Lung DiseaseLung InflammationImmunodeficienciesImmunology	2019	12
Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment Rajeev Rudraraju, Matthew J. Gartner, Jessica A. Neil, Stem Cell Reports Lung CellsCell TherapyInflammatory Lung DiseaseLung InflammationViral Pathogenesis	2023	12
Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection Julie McAuley, Yi‐Mo Deng, Brad Gilbertson, Virology Journal	2017	10

Page 1